Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Luffariellolide

Phospholipase inhibitor
 
BML-ST310-0001 1 mg 137.00 USD
Do you need bulk/larger quantities?
 
Replaces Prod. #: ALX-350-038

Marine sesterterpenoid. Structurally related to manoalide (Prod. No. BML-EI177). Anti-inflammatory phospholipase A2 (PLA2) inhibitor (IC50=0.23µM). Less potent than manoalide, but partially reversible (IC50=0.23µM, bee venom PLA2). Inhibits human recombinant sPLA2 (IC50=9.3µM) selectively over cPLA2.

Product Specification

Formula:C25H38O3
 
MW:386.6
 
Source:Isolated from sponge Luffariella sp.
 
CAS:111149-87-2
 
Purity:≥98% (TLC)
 
Appearance:Pale yellow oil.
 
Solubility:Soluble in DMSO or 100% ethanol.
 
Shipping:Ambient
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least 1 year after receipt when stored at -20°C. Stock solutions are stable for up to 3 months at -20°C.
 
Handling:Protect from light.
 
Technical Info/Product Notes:Note: Product is not sterile
 
bml-st310
Please mouse over
bml-st310

Product Literature References

Characterization and pharmacological modulation of soluble phospholipase A2 generated during glycogen-induced rat peritonitis: L.A. Marshall, et al.; Agents Actions 37, 60 (1992), Abstract;
PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase: K.B. Glaser, et al.; Agents Actions 34, 89 (1991), Abstract;
Luffariellolide, an anti-inflammatory sesterterpene from the marine sponge Luffariella spp.: K.F. Albizati, et al.; Experientia 43, 949 (1987),

Related Products

Manoalide 

Phospholipase inhibitor
75088-80-1, ≥98% (TLC) | Print as PDF
 
BML-EI177-0001 1 mg 190.00 USD
Do you need bulk/larger quantities?
 

Related Literature

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,